Professional Documents
Culture Documents
29-Sep-18 1
Definition
29-Sep-18 2
Classification
Phenothiazine derivatives
Butyrophenol derivatives
Rauwolfia alkaloids
Benzodiazipine
α2 – adrenergic agonists
Central muscle relaxants
29-Sep-18 3
Phenothiazine derivatives
Members
Chlorpromazine
Promazine
Acepromazine
Propiopromazine
Triflupromazine
29-Sep-18 4
Phenothiazine Derivates
► Classification
29-Sep-18 6
29-Sep-18 7
29-Sep-18 8
Properties
They are major tranqulizers
Cause sedation
Block dopamine receptor
Depress cortical areas
Block α1 – receptors
Antihistamne, anticholinergic, antisposmotic
activity
Vasodilation, decrease B.P
No analgesia
Poor relaxation
29-Sep-18 9
Uses
a) Tranqulizer
b) Preanaesthetic
c) Control or restrain
d) Sedation, calm
e) Anti-emetic
f) May potentiate O.P toxicity
g) Paramphymosis
Dose: Acepromazine: 0.05mg/kg
Chlorpromazine: 0.5 – 1 mg/kg
29-Sep-18 10
Butyrophenone Derivatives
Members
Droperidol
Haloperidol
Azaperine
29-Sep-18 11
Properties
Dopamine blocking
α1 block, less
Less sedative
Anti-emetic potent
More potent than chlorpromazine as an atiemetic
Innovar – vet (Droperidol + Fentanyl)
29-Sep-18 12
Rauwolfia alkaloids
Members
Reserpine
Properties
Depletion of N.E from storage vesicles
Cause sedation
Effect for a longer period
29-Sep-18 13
Benzodiazepines
Members
Diazepam (Valium)
Zolezepam
Chlorodiazepoxide (Librium)
Midazolam
29-Sep-18 14
Properties
Enhance binding of GABA, open Cl- channel,
hyperpolarization
Minor tranqulizer
Sedative
Poor analgesic
Relaxation of muscle
Anti-convulsant
Pre-anaesthetic
Antidote: Flumazenil
29-Sep-18 15
α2 – Agonist
Members
Xylazine
Detomidine
Clonidine
Medetomidine
29-Sep-18 16
Properties
Sedative
Hypnotic
Analgesic
Relaxation
Pre-anaesthetic
α2 –
agonist
Dose dependant
Decrease Insulin, increase glucose
Yohimbine (Antidote)
29-Sep-18 17
Central Muscle Relaxants
Members
Meprobamate
Mephenesin
Guaifenesin [Glyceryl Guaicolate Ether] (GGE)
29-Sep-18 18
Properties
Centralmuscle relaxation
Pre-anaesthetic
Poor anaesthetic
Poor sedative
Poor analgesic
29-Sep-18 19